Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran.
Shahriari-Ahmadi A, Fahimi A, Payandeh M, Sadeghi M.
Shahriari-Ahmadi A, et al.
Asian Pac J Cancer Prev. 2015;16(17):7603-6. doi: 10.7314/apjcp.2015.16.17.7603.
Asian Pac J Cancer Prev. 2015.
PMID: 26625769
Free article.
For the FOLFOX regimen, patients received oxaliplatin, 85 mg/m2, every 2 weeks for 12 courses and with the XELOX regimen, oxaliplatin was 130 mg/m(2), every 3 weeks for 8 courses. Based on Common Toxicity Criteria (CTC or NCI-CTC v.3), the patients were divided into 5 grou …
For the FOLFOX regimen, patients received oxaliplatin, 85 mg/m2, every 2 weeks for 12 courses and with the XELOX regimen, oxaliplatin was 13 …